309 related articles for article (PubMed ID: 27196489)
1. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
[TBL] [Abstract][Full Text] [Related]
2. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
3. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.
Yuan X; Wu H; Xu H; Han N; Chu Q; Yu S; Chen Y; Wu K
Sci Rep; 2015 May; 5():10338. PubMed ID: 25996086
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
[TBL] [Abstract][Full Text] [Related]
8. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract][Full Text] [Related]
10. NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.
Sasnauskienė A; Jonušienė V; Krikštaponienė A; Butkytė S; Dabkevičienė D; Kanopienė D; Kazbarienė B; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(1):14-8. PubMed ID: 25060200
[TBL] [Abstract][Full Text] [Related]
11. Expression of Notch 3 and Jagged 1 Is Associated With Merkel Cell Polyomavirus Status and Prognosis in Merkel Cell Carcinoma.
Wardhani LO; Matsushita M; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Anticancer Res; 2019 Jan; 39(1):319-329. PubMed ID: 30591475
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of Notch2 in lung cancer.
Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T
Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642
[TBL] [Abstract][Full Text] [Related]
13. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Mandula JK; Sierra-Mondragon RA; Jimenez RV; Chang D; Mohamed E; Chang S; Vazquez-Martinez JA; Cao Y; Anadon CM; Lee SB; Das S; Rocha-Munguba L; Pham VM; Li R; Tarhini AA; Furqan M; Dalton W; Churchman M; Moran-Segura CM; Nguyen J; Perez B; Kojetin DJ; Obermayer A; Yu X; Chen A; Shaw TI; Conejo-Garcia JR; Rodriguez PC
Immunity; 2024 May; 57(5):1124-1140.e9. PubMed ID: 38636522
[TBL] [Abstract][Full Text] [Related]
14. Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC.
Sinicropi-Yao SL; Amann JM; Lopez DLY; Cerciello F; Coombes KR; Carbone DP
J Thorac Oncol; 2019 Feb; 14(2):223-236. PubMed ID: 30408569
[TBL] [Abstract][Full Text] [Related]
15. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of Notch signaling-associated proteins in esophageal squamous cell carcinoma].
Yuan Y; Hu Y; Zhao Y; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):909-13. PubMed ID: 26404689
[TBL] [Abstract][Full Text] [Related]
17. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling and targeted therapy in non-small cell lung cancer.
Sun J; Dong M; Xiang X; Zhang S; Wen D
Cancer Lett; 2024 Mar; 585():216647. PubMed ID: 38301911
[TBL] [Abstract][Full Text] [Related]
19. JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
Chang WH; Ho BC; Hsiao YJ; Chen JS; Yeh CH; Chen HY; Chang GC; Su KY; Yu SL
PLoS One; 2016; 11(3):e0150355. PubMed ID: 26930648
[TBL] [Abstract][Full Text] [Related]
20. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
